Recursion Pharmaceuticals, Inc. RXRX Professional Service Fees Payable
Professional Service Fees Payable at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s professional service fees payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s professional service fees payable?
- Recursion Pharmaceuticals, Inc. (RXRX) reported professional service fees payable of $1.88M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s professional service fees payable changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s professional service fees payable decreased by 34.3% year-over-year, from $2.86M to $1.88M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s professional service fees payable?
- Over 4 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s professional service fees payable has grown at a 233.2% compound annual growth rate (CAGR), from $10K to $1.23M.